Occasional review
Interactions between corticosteroids and
agonists
D R Taylor, R J Hancox
Department
of Medicine, Dunedin School of Medicine, P O Box 913, Dunedin, New
Zealand
Correspondence to: Dr D R Taylor e-mail: robin.taylor@stonebow.otago.ac.nz
Received 5 January 2000; Accepted for publication 20 January 2000
| The first 150 words of the full text of this article appear below. |
| |
Introduction |
|---|
Inhaled corticosteroids and
agonists are the most
frequently prescribed drugs in the management of chronic asthma.
Current guidelines emphasise their complementary role. Inhaled
corticosteroids are the treatment of choice for all but the mildest of
disease. Short acting
agonists are recommended for "as
required" relief of asthma symptoms, whereas long acting agents are
indicated as a supplement to anti-inflammatory therapy if breakthrough
symptoms persist.1 Thus, co-prescribing is commonplace.
However, despite dynamic interactions between endogenous
glucocorticoids and catecholamines in vivo, it is only recently that
interest in the possibility of drug interactions has developed. Two
topical and clinically relevant questions arise. Firstly, do positive
interactions occur, thus providing theoretical justification for
current trends to use combination products incorporating a long acting
agonist and a corticosteroid? Secondly, do negative interactions
occur which might explain the apparent paradox that, despite increasing use of the two therapies over the last 30 years, the overall burden
This article has been cited by other articles:
-
Salpeter, S. R., Buckley, N. S., Ormiston, T. M., Salpeter, E. E.
(2006). Meta-Analysis: Effect of Long-Acting {beta}-Agonists on Severe Asthma Exacerbations and Asthma-Related Deaths. ANN INTERN MED
144: 904-912
[Abstract] [Full Text] -
Giembycz, M. A., Newton, R.
(2006). Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways.. Eur Respir J
27: 1286-1306
[Abstract] [Full Text] -
Koopmans, J G, Lutter, R, Jansen, H M, van der Zee, J S
(2006). Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma. Thorax
61: 306-313
[Abstract] [Full Text] -
Pellegrino, M. A., D'Antona, G., Bortolotto, S., Boschi, F., Pastoris, O., Bottinelli, R., Polla, B., Reggiani, C.
(2004). Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice. Exp Physiol
89: 89-100
[Abstract] [Full Text] -
Tse, R., Marroquin, B. A., Dorscheid, D. R., White, S. R.
(2003). {beta}-Adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol.
285: L393-L404
[Abstract] [Full Text] -
Yeh, C.-K., Hymer, T. K., Sousa, A. L., Zhang, B.-X., Lifschitz, M. D., Katz, M. S.
(2003). Epidermal growth factor upregulates beta -adrenergic receptor signaling in a human salivary cell line. Am. J. Physiol. Cell Physiol.
284: C1164-C1175
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
